Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Sales (2016 - 2025)

iBio (IBIO) has disclosed Return on Sales for 16 consecutive years, with 82.46% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 6064.0% to 82.46% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 82.46% through Dec 2025, down 4666.0% year-over-year, with the annual reading at 45.94% for FY2025, 388.0% down from the prior year.
  • Return on Sales for Q4 2025 was 82.46% at iBio, down from 57.2% in the prior quarter.
  • The five-year high for Return on Sales was 3.14% in Q1 2022, with the low at 130.22% in Q4 2023.
  • Average Return on Sales over 5 years is 41.54%, with a median of 25.66% recorded in 2022.
  • The sharpest move saw Return on Sales plummeted -10472bps in 2023, then soared 10840bps in 2024.
  • Over 5 years, Return on Sales stood at 19.58% in 2021, then plummeted by -30bps to 25.5% in 2022, then plummeted by -411bps to 130.22% in 2023, then soared by 83bps to 21.82% in 2024, then crashed by -278bps to 82.46% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 82.46%, 57.2%, and 25.82% for Q4 2025, Q3 2025, and Q2 2025 respectively.